14
Registered trials
10
Recruiting
1
Completed trials
1
Countries active
38
Unique IMPs
100%
Results reported
100%
1 of 1 completed trials have published summary results (EU CTR Article 37 — 12-month obligation).
Top IMPs
FENTANYL CITRATE
2
PROPOFOL
2
ABROCITINIB
1
ALLOGENEIC PERIPHERAL BLOOD-DERIVED CD56+ NATURAL KILLER CELLS, CO-CULTURED WITH K562-MB15-41BBI CELL LINE
1
ASCORBIC ACID, SODIUM ASCORBATE, POTASSIUM CHLORIDE, SODIUM CHLORIDE, SODIUM SULFATE ANHYDROUS, MACROGOL 3350
1
BARICITINIB
1
BOTULINUM TOXIN TYPE A - HAEMAGGLUTININ COMPLEX
1
CART45RA-NKG2D CELLS
1
CISPLATIN
1
DOBUTAMINE
1
DOCETAXEL
1
DOXORUBICIN HYDROCHLORIDE
1
All trials
14 totalShowing 1–14 of 14 trials